Daniel J. Kruger, PhD
Research Associate Professor
Research Scientist
Psychology
Public Health
Jacobs School of Medicine and Biomedical Sciences
猛料视频, State 猛料视频 of New York
Contact Information
UB Downtown Gateway
77 Goodell St.
Suite 420
Buffalo, NY 14203
Email: djkruger@buffalo.edu
Primary Research Areas
Medical Cannabis; novel and emerging cannabinoids; therapeutic use of psychedelics; integration of Cannabis and psychedelics with healthcare and health professions education
Selected Publications
Kruger, D.J., Barron, J., Herberholz, M., & Boehnke, K.F. (2023). Preferences and support for psychedelic policies and practices among those using psychedelics. Journal of Psychoactive Drugs.
Kruger, D.J., Bone, C.B., Meacham, M.C., Klein, C., & Kruger, J. S. (2023). THC-O-acetate: Scarce evidence for a psychedelic cannabinoid. Journal of Psychoactive Drugs.
Bone, C.B., Klein, C., Munger, K., Strongin, R.M., Kruger, D.J., Meacham, M.C., & Kruger, J. S. (2023). Reviewing the risk of ketene formation in dabbing and vaping THC-O-acetate. Cannabis and Cannabinoid Research.
Kruger, D.J., Gerlach, J., Kruger, J.S., Mokbel, M.M., Clauw, D.J., & Boehnke, K.F. (2023). Physicians’ attitudes and practices regarding Cannabis and recommending medical Cannabis use. Cannabis and Cannabinoid Research.
Kruger, D.J., Enghoff, O., Herberholz, M., Barron, J., & Boehnke, K.F. (2023). “How do I learn more about this?”: Utilization and trust of psychedelic information sources among people naturalistically using psychedelics. Journal of Psychoactive Drugs.
Kruger, D.J. & Kruger, J.S. (2023). Consumer experiences with delta-8-THC: Medical use, pharmaceutical substitution, and comparisons with delta-9-THC. Cannabis and Cannabinoid Research, 8, 166-173.
Kruger, D.J., Karahmet, A., Kaplan, S.M., Redfield, J., Stacy, T., Agarwal, V., Faqqouseh, M., & Bone, C.B. (2023). Social media discussions on THC-O-acetate: A content analysis. Cannabis, 6 (2).
Kruger, D.J., Glynos, N.G., Fields, C.W., Herberholz, M., & Boehnke, K.F. (2023). An assessment of psychedelic knowledge among people using psychedelics naturalistically. Journal of Psychoactive Drugs, 55, 420-424.
Allard, N.C., Kruger, J.S., & Kruger, D.J. (2023). Cannabis advertising policies in the United States: State-level variation and comparison with Canada. Cannabis and Cannabinoid Research, 8, 505-509.
Holman, A., Kruger, D.J., Lucas, P., Ong, K., Bergmans, R.S., Boehnke, K.F. (2023). Healthcare provider and medical cannabis patient communication regarding referral and medication substitution: The Canadian context. Journal of Cannabis Research, 4, 32.
Kruger, J.S., & Kruger, D.J. (2022). Delta-8-THC: Delta-9-THC’s nicer younger sibling? Journal of Cannabis Research, 4, 4.
Kruger, D.J., Mokbel, M.M., Clauw, D.J., & Boehnke, K.F. (2022). Assessing healthcare providers’ knowledge of medical Cannabis. Cannabis and Cannabinoid Research, 7, 501-507.